Amy Dixon is a Patient Advocate, Elite Paratriathlete, and motivational speaker, speaking on television and radio and at seminars around the world, on subjects pertaining to triumph over adversity, leadership, team work, rare disease management, patient advocacy, and how to achieve a full life despite devastating setbacks.
Amy lost 98% of her sight due to a rare type of Uveitis (an inflammatory autoimmune eye disease), and now travels the world with her guide dog Woodstock by her side, speaking to groups about her passion for empowering patients to educate and advocate for themselves in the face of illness and disease. She is the Vice President of Glaucoma Eyes International Organization, where she serves as a coach and mentor to many visually impaired athletes, eye disease and autoimmune disease patients, helping them live lives beyond their disability and disease through her vast resources and expertise.
She is a Certified Wine Specialist from the Society of Wine Educators, with 20 years’ experience as a wine expert and educator, a graduate of the Dale Carnegie Institute for Public Speaking and Leadership.
Amy is also an elite Paratriathlete, 2016 USA Paratriathlon National Team Member, and currently ranked #3 in the world in the sport of Paratriathlon as a visually impaired female. Last year, she founded Camp “No Sight No Limits” to train more blind athletes to become elite in the sport, ensuring the future of blind triathlon in the USA. Amy also is the currently ITU Aquathlon World Champion. She is currently racing and training to make the US Team for the Tokyo Paralympics in 2020.
Amy speaks about empowering yourself to overcome obstacles, such as illness, injury and professional challenges by educating yourself and becoming an expert in what challenges you. She shows why building the right team and utilizing technology is the key to success in life, and life with rare disease. Her message, “One does not need sight to have vision,” powerfully reflects her determination to succeed in all aspects of her professional and personal and athletic life.
On Friday, December 15, at 1:00pm, Amy will join MedTech Impact 2017 Conference Chair Dennis Robbins, M.P.H, Ph.D, and fellow panelists Jennifer Joe, M.D., CEO & Founder, Medstro.com; Rain Henderson, Advisor, Clinton Foundation; and Peter Tippett, M.D., Ph.D., CEO, HealthCelerate, for a discussion around becoming a vanguard rather than a victim when faced with uncertainty and adversity. For more information, visit www.MedTechImpact.com/agenda.
For more information about Amy Dixon, visit http://www.amydixonusa.com.